Michael Sumner

Inovio

BIOGRAPHY

Michael Sumner is the chief medical officer at INOVIO, where he oversees the company’s clinical-stage pipeline of DNA medicines, along with global clinical development, clinical operations, biostatistics, regulatory affairs, pharmacovigilance, and medical affairs. He brings over 25 years of experience across late-stage product approvals and global commercialization in multiple therapeutic areas.

Michael previously served as CMO of Orexo AB and held senior leadership roles at Novartis, Aventis Behring, Novo Nordisk, and Shire Pharmaceuticals, contributing to major advances in pharmaceutical and clinical development.